tradingkey.logo

IRadimed Corp

IRMD
查看詳細走勢圖
97.060USD
+0.460+0.48%
收盤 12/24, 13:00美東報價延遲15分鐘
1.23B總市值
58.23本益比TTM

IRadimed Corp

97.060
+0.460+0.48%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.48%

5天

+3.23%

1月

+7.47%

6月

+60.48%

今年開始到現在

+76.47%

1年

+79.04%

查看詳細走勢圖

TradingKey IRadimed Corp股票評分

單位: USD 更新時間: 2025-12-24

操作建議

IRadimed Corp當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名29/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價99.00。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

IRadimed Corp評分

相關信息

行業排名
29 / 206
全市場排名
100 / 4562
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 2 分析師
買入
評級
99.000
目標均價
+3.69%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

IRadimed Corp亮點

亮點風險
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
業績高增長
公司營業收入穩步增長,連續3年增長37.41%
業績增長期
公司處於發展階段,最新年度總收入73.24M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入73.24M美元
高分紅
公司屬於高分紅公司,最新股息支付率29.64%
估值高估
公司最新PE估值58.23,處於3年歷史高位
機構減倉
最新機構持股7.41M股,環比減少11.47%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉27.00股

IRadimed Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

IRadimed Corp簡介

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
公司代碼IRMD
公司IRadimed Corp
CEOSusi (Roger)
網址https://www.iradimed.com/

常見問題

IRadimed Corp(IRMD)的當前股價是多少?

IRadimed Corp(IRMD)的當前股價是 97.060。

IRadimed Corp 的股票代碼是什麼?

IRadimed Corp的股票代碼是IRMD。

IRadimed Corp股票的52週最高點是多少?

IRadimed Corp股票的52週最高點是98.240。

IRadimed Corp股票的52週最低點是多少?

IRadimed Corp股票的52週最低點是47.232。

IRadimed Corp的市值是多少?

IRadimed Corp的市值是1.23B。

IRadimed Corp的淨利潤是多少?

IRadimed Corp的淨利潤為19.23M。

現在IRadimed Corp(IRMD)的股票是買入、持有還是賣出?

根據分析師評級,IRadimed Corp(IRMD)的總體評級為買入,目標價格為99.000。

IRadimed Corp(IRMD)股票的每股收益(EPS TTM)是多少

IRadimed Corp(IRMD)股票的每股收益(EPS TTM)是1.667。
KeyAI